HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

antileukinate

Also Known As:

Ac-Arg-Arg-Trp-Trp-Cys-Arg-amide; Ac-RRWWCR-NH2; acetyl-arginyl-arginyl-tryptophyl-tryptophyl-cysteinyl-argininamide

Networked: 9 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Oligopeptides: 519
    - antileukinate: 9

Experts

1.	Miller, Edmund J: 3 articles (07/2012 - 06/2003)
2.	Hayashi, Shinichiro: 2 articles (10/2005 - 06/2003)
3.	Hayashi, S: 2 articles (01/2002 - 01/2000)
4.	Miller, E J: 2 articles (01/2002 - 01/2000)
5.	Ahmed, Mohamed N: 1 article (07/2012)
6.	Codipilly, Champa N: 1 article (07/2012)
7.	Min, Jae H: 1 article (07/2012)
8.	Nasim, Sonya: 1 article (07/2012)
9.	Bhatia, Madhav: 1 article (01/2007)
10.	Hegde, Akhil: 1 article (01/2007)

Related Diseases

1.	Acute Lung Injury 01/01/2002 - "These findings suggest that Antileukinate is able to inhibit acute lung injury by suppressing neutrophil mobilization induced by CXC-chemokines." 01/01/2002 - "This study was undertaken to investigate the effect of subcutaneously administered Antileukinate on experimental bleomycin-induced acute lung injury in mice, in which CXC-chemokines have been reported to be involved. " 01/01/2002 - "Antileukinate, a hexapeptide inhibitor of CXC-chemokine receptor, suppresses bleomycin-induced acute lung injury in mice."
2.	Lung Injury 01/10/2007 - "This study aims to evaluate the effect of treatment with antileukinate on acute pancreatitis and the associated lung injury in mice. " 01/10/2007 - "Treatment with antileukinate, a CXCR2 chemokine receptor antagonist, protects mice against acute pancreatitis and associated lung injury." 01/10/2007 - "Treatment with antileukinate protected mice against acute pancreatitis and associated lung injury, showing thereby that anti-chemokine therapy may be of value in this condition."
3.	Pancreatitis 01/10/2007 - "This study aims to evaluate the effect of treatment with antileukinate on acute pancreatitis and the associated lung injury in mice. " 01/10/2007 - "Treatment with antileukinate, a CXCR2 chemokine receptor antagonist, protects mice against acute pancreatitis and associated lung injury." 01/10/2007 - "Treatment with antileukinate protected mice against acute pancreatitis and associated lung injury, showing thereby that anti-chemokine therapy may be of value in this condition."
4.	Edema (Dropsy) 01/01/2002 - "Histopathological studies revealed that treatment with Antileukinate markedly suppressed inflammatory cell infiltration and interstitial lung edema. "
5.	Neoplasms (Cancer) 01/01/2000 - "Administration of antileukinate in vivo inhibited the tumor growth of adenocarcinoma A549. " 01/01/2000 - "Finally, antileukinate inhibition of human, lung adenocarcinoma tumor growth, was determined in BALB/c nude mice. " 01/01/2000 - "Inhibition of alpha-chemokine binding to tumor cells was assessed in the presence and absence of the hexapeptide, antileukinate. " 03/01/1999 - "This raises the interesting possibility of alpha-chemokine receptor inhibitors, such as antileukinate, in the treatment of cancer where angiogenesis is an important factor for tumour growth."

Related Drugs and Biologics

1.	CXC Chemokines
2.	Bleomycin (Blenoxane)
3.	Chemokine Receptors
4.	CXCR Receptors
5.	Intercellular Signaling Peptides and Proteins (Growth Factors)
6.	HMGB1 Protein (HMG1)
7.	Chemokines
8.	Interleukin-8 (Interleukin 8)
9.	Proteins (Proteins, Gene)
10.	Ovalbumin

Related Therapies and Procedures

1.	Therapeutics